Current Issue

Cover Story

Benchmarking HME

Do you know whether your home medical equipment business is being run efficiently and profitably?

HomeCareXtra

Cover Story

Getting Back To Business

The effects of Medicare's competitive bidding delay are a complicated matter.

Marketplace

Schwarz, Price Ask Congress to Repeal DRA Oxygen Policy

WASHINGTON--Reps. Joe Schwarz, R-Mich., and Tom Price, R-Ga., have sent a "Dear Colleague" letter to other members of Congress urging them to co-sponsor a bill that would repeal the oxygen capped rental provision in the Deficit Reduction Act.

The congressmen, who are both physicians, introduced the bill earlier this month (see HomeCare Monday, June 5).

The text of the letter follows:

"As physicians, we are writing you today to urge you to cosponsor H.R. 5513, the Home Oxygen Patient Protection (HOPP) Act. The HOPP Act aims to protect the nearly one million oxygen patients in the Medicare program who receive oxygen therapy in their homes.

"As you may know, a provision that was added to the Deficit Reduction Act of 2005 changes oxygen from continuous rental to a rent-to-purchase model so the beneficiary will be required to assume ownership of oxygen devices after 36 months of rental. Congress did not have any time to consider the impact of this policy through hearings or any other deliberative process before the vote.

"Medical oxygen is a highly regulated drug that requires a prescription. A number of organizations, including the American Lung Association, have expressed serious concerns about the health and safety aspects of the new policy, which will require Medicare beneficiaries to own the complex oxygen equipment required for their therapy.

"This very simple bill repeals the change in Medicare policy for oxygen therapy enacted in the DRA.

"We are keenly interested in making Medicare more efficient and less costly. However, policy that affects treatment for Americans who require oxygen because they suffer from chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, lung cancer or other respiratory diseases must be considered from both a clinical as well as an economic perspective. Congress has not considered the clinical dimensions of this issue."

Back to Top

Browse previous Issues

October 2008

September 2008

August 2008

July 2008

June 2008

May 2008